Literature DB >> 8112982

Cortical lenticular opacification: distribution and location in a longitudinal study.

O D Schein1, S West, B Muñoz, S Vitale, M Maguire, H R Taylor, N M Bressler.   

Abstract

PURPOSE: To examine the distribution of cortical opacification of the lens by lens quadrant in a longitudinal study.
METHODS: In 1990, a follow-up assessment of a cohort of Chesapeake Bay watermen, initially studied in 1985, was performed. Four hundred thirty-seven subjects (834 eyes) had gradable cortical photographs for at least one eye in both 1985 and 1990. Cortical photographs were graded by both estimating total area and determining the quadrant with the greatest degree of cortical opacification.
RESULTS: The prevalence and severity of cortical opacification increased with age with a high degree of concordance (84%) between eyes. For the 47 eyes with cortical opacification > or = 1/8 at baseline, the principal locations of opacification were: inferonasal 63.8%, inferotemporal 17.0%, superonasal 6.4%, and superotemporal 12.8% (P < 0.001, compared with equal distribution by quadrant). Five-year development of new cortical opacification and five-year progression of existing cortical opacification showed even greater preferential occurrence in the inferonasal quadrant of the lens.
CONCLUSIONS: In this population, the inferonasal quadrant of the lens is the principal site of cortical opacification in both cross-sectional and longitudinal assessment. This finding is consistent with the hypothesis that sunlight exposure is a significant risk factor for cortical opacification.

Mesh:

Year:  1994        PMID: 8112982

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

Review 1.  Prevention strategies for age related cataract: present limitations and future possibilities.

Authors:  N G Congdon
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

2.  UV-B-induced DNA damage and repair in the mouse lens.

Authors:  Rosana Mesa; Steven Bassnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-17       Impact factor: 4.799

3.  The use of films to simulate age-related declines in yellow vision.

Authors:  C A Yoshida; S Sakuraba
Journal:  J Occup Rehabil       Date:  1996-06

4.  PARP-1/PAR Activity in Cultured Human Lens Epithelial Cells Exposed to Two Levels of UVB Light.

Authors:  Caroline S Cencer; Shravan K Chintala; Tenira J Townsend; Daniel P Feldmann; Mirna A Awrow; Nahrain A Putris; Mason E Geno; Maria G Donovan; Frank J Giblin
Journal:  Photochem Photobiol       Date:  2017-09-15       Impact factor: 3.421

5.  The differential effect of ultraviolet light exposure on cataract rate across regions of the lens.

Authors:  Alison G Abraham; Christopher Cox; Sheila West
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

6.  The concentration of light in the human lens.

Authors:  J C Merriam
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 7.  Light damage revisited: converging evidence, diverging views?

Authors:  C Remé; J Reinboth; M Clausen; F Hafezi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

8.  Risk factors for age related cataract in a rural population of southern India: the Aravind Comprehensive Eye Study.

Authors:  P K Nirmalan; A L Robin; J Katz; J M Tielsch; R D Thulasiraj; R Krishnadas; R Ramakrishnan
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

9.  Cx43, ZO-1, alpha-catenin and beta-catenin in cataractous lens epithelial cells.

Authors:  Anshul I Arora; Kaid Johar; Devarshi U Gajjar; Darshini A Ganatra; Forum B Kayastha; Anuradha K Pal; Alpesh R Patel; S Rajkumar; Abhay R Vasavada
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

10.  Quantification of dolichol in the human lens with different types of cataracts.

Authors:  Devarshi Gajjar; Adam Jozwiak; Ewa Swiezewska; Bhagwat Alapure; Trilok Parmar; Kaid Johar; Abhay R Vasavada
Journal:  Mol Vis       Date:  2009-08-11       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.